MedPath

Maximal Repair Versus Bridging Reconstruction With BioBrace®

Not Applicable
Recruiting
Conditions
Rotator Cuff Tears
Bioinductive Implant
Interventions
Procedure: Repair
Procedure: Bridging Reconstruction using BioBrace
Registration Number
NCT05959733
Lead Sponsor
Nova Scotia Health Authority
Brief Summary

The purpose of this study is to determine if using BioBrace® to reconstruct the gap in the rotator cuff tears lead to better results for patients compared to the traditional maximal repair method. This study will use a variety of clinical, radiographic, and functional outcome measures. Specifically, the researchers will be comparing the re-tear rate, patient reported outcomes, shoulder strength, range of motion, muscle activation, in-vivo biomechanics, and other radiographic outcomes using x-ray and MRI.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • magnetic resonance imaging (MRI) proven diagnosis of a large or massive (> 3cm), two-tendon (supraspinatus and infraspinatus) tear of the shoulder rotator cuff
  • over 18 years of age
Read More
Exclusion Criteria
  • glenohumeral osteoarthritis
  • Western Ontario rotator cuff score >60
  • uncontrolled diabetes (Hgb A1C >7%)
  • pregnant
  • local or systemic infection
  • inability to cooperate with and/or comprehend post-operative instructions
  • MRI proven non-vascular sites
  • poor nutritional state (Alb <30 g/L)
  • cancer
  • paralysis of the shoulder
  • contracture of the shoulder
  • patients unable to provide informed consent for the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RepairRepairThis group will undergo a rotator cuff repair procedure.
Bridging Reconstruction using BioBraceBridging Reconstruction using BioBraceThis experimental group will undergo bridging reconstruction using the bioinductive implant, BioBrace.
Primary Outcome Measures
NameTimeMethod
Radiographic or clinical failure2 years

The primary outcome measure for this study will be radiographic and/or clinical failure defined as a rotator cuff tear of equal or larger size than at baseline or does not meet WORC score MCID compared to baseline at any follow up

Secondary Outcome Measures
NameTimeMethod
Western Ontario Rotator Cuff Index (WORC)Baseline, 6-month, 1-year, 2-years

WORC will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years

Muscle Atrophy2 year

Using MRI, muscle atrophy will be measured using Warner's classification between groups.

Acromiohumeral Distance2 year

Acromiohumeral distance (AHD) will be measured on pre- and post-operative x-rays.

Fatty Infiltration2 year

Fatty infiltration using the Goutallier classification will be used and identified

Healing Rate2 year

To measure the structural integrity of the surgery, Sugaya method will be used.

American Shoulder and Elbow Surgeon surveyBaseline, 6-month, 1-year, 2-years

American Shoulder and Elbow Surgeon survey will be measured pre-operatively, and post-operatively and 6-months, 1-year, and 2-years

EQ-5D-5LBaseline, 6-month, 1-year, 2-years

EQ-5D-5L for overall health will be measured pre-operatively, and post-operatively at 6-months, 1-year, and 2-years

Range of motionBaseline, 6-month, 1-year, 2-years

The range of motion, measured in degrees for flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years

Shoulder strengthBaseline, 6-month, 1-year, 2-years

The strength of patients flexion, extension, abduction, internal, and external rotation will be measured. These are measured and compared pre-operatively, and post-operatively and 6-months, 1-year, and 2-years

Biomechanics and Muscle ActivityBaseline and 2 years

Pre- and post-operative (1-year) in-vivo biomechanics and electromyography will be compared between groups during a standardized shoulder lifting study in a laboratory based environment.

Trial Locations

Locations (1)

Nova Scotia Health Authority

🇨🇦

Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath